Related references
Note: Only part of the references are listed.Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors
S. M. Cadarette et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Measuring and improving adherence to osteoporosis pharmacotherapy
Suzanne M. Cadarette et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
I. Imaz et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe
Ethel S. Siris et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Bisphosphonates for postmenopausal osteoporosis: Determining duration of treatment
Piet Geusens
Current Osteoporosis Reports (2009)
Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis
Catherine MacLean et al.
ANNALS OF INTERNAL MEDICINE (2008)
Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday
J. R. Curtis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Fracture risk remains reduced one year after discontinuation of risedronate
N. B. Watts et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis
Prajesh Kothawala et al.
MAYO CLINIC PROCEEDINGS (2007)
A systematic review of persistence and compliance with bisphosphonates for osteoporosis
J. A. Cramer et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Gaps in treatment among users of osteoporosis medications: The dynamics of noncompliance
M. Alan Brookhart et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Patient adherence to osteoporosis medications - Problems, consequences and management strategies
Alexandra Papaioannou et al.
DRUGS & AGING (2007)
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial
Dennis M. Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Persistence with weekly alendronate therapy among postmenopausal women
J. C. Lo et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Persistence with bisphosphonate therapy in older people
M Melo et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Compliance with osteoporosis medications
DH Solomon et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
JA Cramer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?
SB Jaglal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Oral bisphosphonates and upper gastrointestinal tract problems: What is the evidence?
B Cryer et al.
MAYO CLINIC PROCEEDINGS (2002)
Summary of meta-analyses of therapies for postmenopausal osteoporosis
A Cranney et al.
ENDOCRINE REVIEWS (2002)
Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment
R Tamblyn et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Share Paper
